[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 017″]
Outset Medical CEO Leslie Trigg brings a career of success in medtech into a new approach to dialysis. Tablo, a sleek device, could enable dialysis companies an easier, cheaper way of providing dialysis to patients.
Before becoming Outset’s President and CEO, Leslie was the company’s Chief Operating Officer and also served as an Executive-in-Residence at Warburg Pincus. Prior to Outset, she was Executive Vice President at Lutonix, a cardiovascular medical device company acquired by CR Bard.